Abstract
A range of isatin-thiazolidinone hybrid analogues were synthesized and their cytotoxicity was evaluated against several cancer cell lines in vitro. The acute toxicity studies in mice models revealed that these analogues possess low systemic toxicity and are safe up to 1600mg/Kg. Among the compounds synthesized, 5-(2-nitrobenzylidene)-2-(isatin-3- azino)-thiazolidin-4-one (CI) has been shown to be the most active, highly promising compound which induced S phase arrest in cell cycle in a time dependent manner. Our initial analysis indicate that incorporation of electron withdrawing group at ortho position of the ring favors over the meta and para positions for eliciting its cytostatic effect. Overall, the in vitro biological evaluation suggests that the growth inhibitory effect of CI is promising and can be studied further.
Keywords: Isatin, thiazolidinone, cancer, cytotoxicity, cell cycle arrest, Isatin-Thiazolidinone Hybrid, Anti-Proliferative Agents, Phosphorylation, threonine, Alzheimer's, anti-proliferative effects, tyrosine kinases, p-glycoprotein, mitochondria, spectrophotometer, tetramethylsilane (TMS), DMEM, DMSO, 3-Thiosemicarbazone, 5-(2-Nitrobenzylidene), 4-Fluorobenzylidene, 4-Hydroxybenzylidene, isopropyl alcohol, ELISA microplate reader, cyclocondensation, NCI ADR Res, benzylidene ring, pharmacological screening, Trivandrum
Medicinal Chemistry
Title: Synthesis and In Vitro Evaluation of Some Isatin-Thiazolidinone Hybrid Analogues as Anti-Proliferative Agents
Volume: 6 Issue: 5
Author(s): P. K. Ramshid, Sankar Jagadeeshan, Anand Krishnan, Mary Mathew, S. Asha Nair and M. Radhakrishna Pillai
Affiliation:
Keywords: Isatin, thiazolidinone, cancer, cytotoxicity, cell cycle arrest, Isatin-Thiazolidinone Hybrid, Anti-Proliferative Agents, Phosphorylation, threonine, Alzheimer's, anti-proliferative effects, tyrosine kinases, p-glycoprotein, mitochondria, spectrophotometer, tetramethylsilane (TMS), DMEM, DMSO, 3-Thiosemicarbazone, 5-(2-Nitrobenzylidene), 4-Fluorobenzylidene, 4-Hydroxybenzylidene, isopropyl alcohol, ELISA microplate reader, cyclocondensation, NCI ADR Res, benzylidene ring, pharmacological screening, Trivandrum
Abstract: A range of isatin-thiazolidinone hybrid analogues were synthesized and their cytotoxicity was evaluated against several cancer cell lines in vitro. The acute toxicity studies in mice models revealed that these analogues possess low systemic toxicity and are safe up to 1600mg/Kg. Among the compounds synthesized, 5-(2-nitrobenzylidene)-2-(isatin-3- azino)-thiazolidin-4-one (CI) has been shown to be the most active, highly promising compound which induced S phase arrest in cell cycle in a time dependent manner. Our initial analysis indicate that incorporation of electron withdrawing group at ortho position of the ring favors over the meta and para positions for eliciting its cytostatic effect. Overall, the in vitro biological evaluation suggests that the growth inhibitory effect of CI is promising and can be studied further.
Export Options
About this article
Cite this article as:
K. Ramshid P., Jagadeeshan Sankar, Krishnan Anand, Mathew Mary, Asha Nair S. and Radhakrishna Pillai M., Synthesis and In Vitro Evaluation of Some Isatin-Thiazolidinone Hybrid Analogues as Anti-Proliferative Agents, Medicinal Chemistry 2010; 6 (5) . https://dx.doi.org/10.2174/157340610793358909
DOI https://dx.doi.org/10.2174/157340610793358909 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets
Current Genomics Novel Approaches to Cancer Therapy Using Oncolytic Viruses
Current Molecular Medicine Perspectives on Brain-Targeting Drug Delivery Systems
Current Pharmaceutical Biotechnology Ellipticines as DNA-Targeted Chemotherapeutics
Current Medicinal Chemistry Potential Pathways for CNS Drug Delivery Across the Blood-Cerebrospinal Fluid Barrier
Current Pharmaceutical Design CD44 and EpCAM: Cancer-Initiating Cell Markers
Current Molecular Medicine Epithelial Mesenchymal Transition in Cancer Progression: Prev entive Phytochemicals
Recent Patents on Anti-Cancer Drug Discovery Targeting the AKT Pathway in Glioblastoma
Current Pharmaceutical Design Immunopathology of Type 1 Diabetes and Immunomodulatory Effects of Stem Cells: A Narrative Review of the Literature
Endocrine, Metabolic & Immune Disorders - Drug Targets Atypical GTPases as Drug Targets
Anti-Cancer Agents in Medicinal Chemistry The Glioblastoma Problem: Targeting by Combined Medicinal Chemistry Approaches
Current Medicinal Chemistry Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?
Current Pharmaceutical Design Angiogenesis Inhibitors: Implications for Combination with Conventional Therapies
Current Pharmaceutical Design Metabolism and the Paradoxical Effects of Arsenic: Carcinogenesis and Anticancer
Current Medicinal Chemistry Direct Targeting of the Ras GTPase Superfamily Through Structure- Based Design
Current Topics in Medicinal Chemistry Cancer T Cell Immunotherapy with Bispecific Antibodies and Chimeric Antigen Receptors
Recent Patents on Anti-Cancer Drug Discovery Immunotherapy of Cancer Based on DC-Tumor Fusion Vaccine
Current Immunology Reviews (Discontinued) Editorial (Thematic Issue: The Kynurenine and Melatonergic Pathways in Psychiatric and CNS Disorders)
Current Pharmaceutical Design Research Highlights BAY 1436032: A Novel Pan-mutant IDH1 Inhibitor Extends Survival of Mice with Experimental Brain Tumors
CNS & Neurological Disorders - Drug Targets Celastrus Orbiculatus Extract Potentiates the Sensitivity of Cisplatin Via Caspase-Depenent Apoptosis in Gastric Cancer
Anti-Cancer Agents in Medicinal Chemistry